Eyebright Medical Valuation
| 688050 Stock | 89.09 0.66 0.74% |
At this time, the firm appears to be fairly valued. Eyebright Medical shows a prevailing Real Value of USD90.22 per share. The current price of the firm is USD89.09. Our model computes the value of Eyebright Medical from reviewing the firm fundamentals such as Profit Margin of 0.27 %, shares outstanding of 189.54 M, and Current Valuation of 17.14 B as well as analyzing its technical indicators and probability of bankruptcy.
Price Book 7.3002 | Enterprise Value 17.1 B | Enterprise Value Ebitda 39.5984 | Price Sales 12.4317 | Trailing PE 45.6872 |
Fairly Valued
Today
Please note that Eyebright Medical's price fluctuation is very steady at this time. Calculation of the real value of Eyebright Medical is based on 3 months time horizon. Increasing Eyebright Medical's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Eyebright Medical is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Eyebright Stock. However, Eyebright Medical's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 89.09 | Real 90.22 | Hype 90.1 |
The real value of Eyebright Stock, also known as its intrinsic value, is the underlying worth of Eyebright Medical Company, which is reflected in its stock price. It is based on Eyebright Medical's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Eyebright Medical's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Eyebright Medical Technology helps investors to forecast how Eyebright stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Eyebright Medical more accurately as focusing exclusively on Eyebright Medical's fundamentals will not take into account other important factors: Eyebright Medical Cash |
|
Eyebright Medical Total Value Analysis
Eyebright Medical Technology is presently estimated to have takeover price of 17.14 B with market capitalization of 16.89 B, debt of 117.94 M, and cash on hands of . Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Eyebright Medical fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
17.14 B | 16.89 B | 117.94 M |
Eyebright Medical Investor Information
About 38.0% of the company shares are owned by insiders or employees . The company last dividend was issued on the 5th of June 2024. Eyebright Medical had 1.8:1 split on the 5th of June 2024. Eyebright Medical Technology is performing exceptionally good at this time. It has a great probability to report excellent financial results in January.Eyebright Medical Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Eyebright Medical has an asset utilization ratio of 31.07 percent. This suggests that the Company is making USD0.31 for each dollar of assets. An increasing asset utilization means that Eyebright Medical Technology is more efficient with each dollar of assets it utilizes for everyday operations.Eyebright Medical Ownership Allocation
Eyebright Medical holds a total of 189.54 Million outstanding shares. Eyebright Medical Technology retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Eyebright Medical Profitability Analysis
The company reported the revenue of 951.18 M. Net Income was 304.43 M with profit before overhead, payroll, taxes, and interest of 491.15 M.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Eyebright Medical's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Eyebright Medical and how it compares across the competition.
About Eyebright Medical Valuation
The stock valuation mechanism determines Eyebright Medical's current worth on a weekly basis. Our valuation model uses a comparative analysis of Eyebright Medical. We calculate exposure to Eyebright Medical's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Eyebright Medical's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 722.9 M | 759.1 M |
Complementary Tools for Eyebright Stock analysis
When running Eyebright Medical's price analysis, check to measure Eyebright Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Eyebright Medical is operating at the current time. Most of Eyebright Medical's value examination focuses on studying past and present price action to predict the probability of Eyebright Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Eyebright Medical's price. Additionally, you may evaluate how the addition of Eyebright Medical to your portfolios can decrease your overall portfolio volatility.
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device |